Martin Health System
772.287.5200
Contact Us:
HomeBack
Breast Cancer




Breast Cancer:  

  • About 1 in 8 women will develop breast cancer in her lifetime
  • Although much less common, breast cancer can also develop in men

NSABP B-43


Disease Stage:
0 (In-situ Disease)
Status: Recruiting patients
Sponsor: National Surgical Adjuvant Breast and Bowel Project (NSABP)
Title: Clinical Trial Comparing Trastuzumab given concurrently with radiation therapy and radiation therapy alone for women with HER-2 positive ductal carcinoma in-situ resected by lumpectomy.
Phase: 3
Purpose: To determine the value or trastuzumab given during radiation therapy compared to radiation therapy alone in preventing the subsequent occurrence of ipsilateral breast cancer recurrence, ipsilateral skin cancer recurrence, or ipsilateral DCIS.

Eligibility:

1. HER-2 positive disease by central testing
2. Disease removed by lumpectomy
3. No invasive breast cancer
4. Good performance status
5. Female



Contact Us

Robert and Carol Weissman Cancer Center 
Clinical Research Program
501 E. Osceola St.
Stuart, FL 34994
772-288-5858, prompt #4

Online Contact Form
Back to Top
Need a Physician?
Call 866.361.HOPE (4673)
FacebookTwitterYouTube
© 2012 Martin Health System | 772.287.5200
Find us on:
you tube

Martin Health System
is a not-for-profit, community-based health care organization